Protocol for Accelerated Recovery in Patients Undergoing Thoracic Surgical Procedures (PROSM). Study Randomized Comparative Between the Adoption of the Proposed Guidelines and the Traditional Method Currently Used in the Institution

Launched by IGOR RENATO LOURO BRUNO DE ABREU · Sep 1, 2017

Keywords

ClinConnect Summary

The PROSM trial is studying a new recovery protocol designed to help patients recover faster after lung surgery, specifically for conditions like lung cancer. The goal is to see if this new approach can reduce hospital stays, lower pain levels, and cut down on treatment costs compared to the traditional methods currently used. To do this, 200 patients who are scheduled for lung surgery, such as segmentectomies or lobectomies, will be divided into two groups. One group will receive the usual care, while the other will follow the new PROSM guidelines.

To be eligible for this study, patients must be 65 years or older and scheduled for elective lung surgery. However, people with certain health issues, like severe heart or liver problems, or those who cannot understand or sign consent, will not be included. Participants can expect to be monitored closely during their surgery and recovery, with their pain and any complications tracked to see which method works better. Overall, this study aims to improve patient outcomes and make lung surgery more efficient and cost-effective.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • patients with elective pulmonary resections (segmentectomies, lobectomies or pneumonectomies) to treat neoplastic lung diseases.
• Exclusion Criteria:
• • unable to read, understand and sign informed consent
• • patients with compromised performance status (ECOG greater than 2)
• • body mass below 60 kg or greater than 120 kg
• • allergy to latex
• • patients with a history of allergy to any of the drugs used in anesthesia for PROSM
• • patients with renal dysfunction
• • liver dysfunction
• • severe cardiac dysfunction (cardiac failure)